John W. Newcomer, M.D. is Professor of Integrated Medical Science at the Charles E. Schmidt College of Medicine at Florida Atlantic University (FAU). Dr. Newcomer has been involved in medical student and residency training in psychiatry for more than 25 years. Dr. Newcomer has served as a principal investigator on research grants funded through the National Institutes of Health (NIH) for over 20 years, and has held a series of research leadership positions at Washington University in St. Louis, the University of Miami in Florida, and at FAU where he served as a Vice Dean in the medical school and in 2014 as Interim Vice President for Research for the university. Dr. Newcomer has received a number of honors and awards, including an Independent Scientist Award from the NIH and placement on the Thomson Reuters List of Highly Cited Researchers in 2014. Dr. Newcomer has served on the Board of Directors for the American Society of Clinical Psychopharmacology since 2006, serves as a longstanding reviewer for the NIH and other funding agencies, and since 2007 has been a member of the Metabolic Disorders Steering Committee of the Biomarkers Consortium of the Foundation for the National Institutes of Health (FNIH). In the public sector, for 13 years he was Chair of the Medicaid Drug Utilization Review Board for the State of Missouri, supporting public oversight for over $1B in pharmacy program expenditures.
Click Dr. Newcomer's Google Scholar page here.